The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to India's first mRNA-based Omicron booster vaccine and it is likely to be rolled out in 2-3 weeks, Gennova Biopharmaceuticals announced on Tuesday.The .
DCGI Granted Emergency Use Authorisation (EUA) To India's First MRNA-Based Omicron Booster Vaccine And It Is Likely To Be Rolled Out In 2-3 Weeks; Gennova Biopharmaceuticals New Delhi, June 20 (IANS) The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to India's first mRNA-based Omicron booster vaccine and it is likely to be rolled out in
The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to India s first mRNA-based Omicron booster vaccine and it is likely to be rolled out in 2-3 weeks, Gennova Biopharmaceuticals announced on Tuesday.